2m 2m 2m 2m 2m 2m 2m
IMMUNOME (IMNM)
NASDAQ
$17.68-$0.32 (-1.80%)
Price as of Oct 22, 2026 7:56 PM EDT- $2.1BMarket Cap
- 13.21%1-Year Change
- BiotechnologyIndustry
IMMUNOME (IMNM)
$17.68-$0.32 (-1.80%)
IMNM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.00 | ||
Change | +$0.08 (+0.45%) | ||
Open | $17.99 | ||
High | $18.44 | ||
Low | $17.85 | ||
Previous Close | $17.92 | ||
Volume | 1,543,955 | ||
30-Day Average Volume | 1,510,248 | ||
1-Week Change | 4.65% | ||
1-Month Change | -28.20% | ||
1-Year Change | 13.21% | ||
3-Year Change | 106.19% | ||
5-Year Change | -0.77% | ||
Fundamentals | |||
Shares Outstanding | 118.0M | ||
Total Assets | $565.4M | ||
Market Cap | $2.1B | ||
Enterprise Value | $1.9B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$73.1M | ||
Free Cash Flow | -$63.9M | ||
EBIT | -$73.1M | ||
EBITDA | -$72.2M | ||
Net Working Capital | $502.7M | ||
EPS | -$0.65 | ||
Enterprise Value/EBITDA | -26 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -28 | ||
PEG | 1 | ||
Price/Free Cash Flow | -33 | ||
Price/Operating Cash Flow | -34 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 1000 | ||
Last Split Date | 12/19/2007 | ||
Earnings & Revenue